Garvan Institute of Medical Research

From Wikipedia, the free encyclopedia
(Redirected from Garvan Institute)
Jump to navigation Jump to search

Garvan Institute of Medical Research
Error creating thumbnail: File missing
FounderSisters of Charity
Established1963; 63 years ago (1963)
MissionMedical research
DirectorProfessor Benjamin Kile[1]
FacultyUniversity of New South Wales
Adjunct facultySt Vincent's Hospital, Sydney
Staffapprox. 750
Location
Victoria Street, Darlinghurst
, , ,
Australia
Websitewww.garvan.org.au

The Garvan Institute of Medical Research is an Australian biomedical research institute located in Darlinghurst, Sydney, New South Wales. Founded in 1963 by the Sisters of Charity as a research department of St Vincent's Hospital, it is now one of Australia's largest medical research institutions, with approximately 750 scientists, students and support staff.

History

[edit | edit source]
File:Old Garvan Institute Building.jpg
Original Garvan Institute building, opened in 1963.

Funds for its establishment were provided by a centenary hospital appeal by the Sisters of Charity for St Vincent's Hospital. Helen Mills, the largest donor, asked for the centre to be named after her father James Patrick Garvan, a distinguished New South Wales parliamentarian and business leader.[2]

File:Garvan Institute Building.jpg
The current Garvan Institute building, completed in 1997, with the Kinghorn Cancer Centre to the left

The Kinghorn Cancer Centre, a A$100 million joint venture between Garvan and St Vincent's Hospital, was opened on 28 August 2012 by Prime Minister Julia Gillard.[3] The centre is named after the Kinghorn Foundation, one of the centre's main benefactors.[4]

In 2014, the institute became one of only three organisations in the world able to sequence the human genome at a base cost below US$1,000 each (the $1,000 genome) when it purchased the next generation of genome-sequencing equipment, which is capable of sequencing 350 genomes a week (18,000 a year).[5]

Professor Chris Goodnow, internationally renowned immunologist, became Executive Director in 2018. He oversaw the development of rapid and affordable genome sequencing and the growing application of personalised medicine.[6]

In 2023, Prof Benjamin Kile, an internationally recognised and highly regarded blood cell molecular biologist, was appointed Executive Director.[7]   Kile has refined the Institute’s strategic focus to genomics, immunology and cancer.[8]

Research

[edit | edit source]

Garvan's medical research is focused on genomics, cancer and immunology

Researchers works across the three above themes, with teams divided into eight divisionsresearch programs.

  • Genomics and Inherited Disease: Harnessing genomics to accelerate the diagnosis and treatment of inherited disease. 
  • Translational Genomics: Unpacking disease through the cell and the genome. 
  • Centre for Population Genomics: Building the largest and most inclusive genomic databases to ensure all Australian communities benefit from genomic health advances. The Centre is a collaboration with the Murdoch Children’s Research Institute.  
  • Cancer Ecosystems: Using the latest molecular techniques to understand the biological systems driving cancer growth. 
  • Cancer Plasticity and Dormancy: Developing new treatment paradigms to overcome treatment resistance in cancer. 
  • Translational Oncology: Transforming cancer therapy and improving patient outcomes. 
  • Precision Immunology: Transform the diagnosis and treatment of diseases affecting the immune system. 
  • Immune Biotherapies: Using mammalian and bacterial immune targeting systems to develop new therapies and better understand the immune system. [9]

Directors

[edit | edit source]

Garvan is affiliated with UNSW Sydney. PhD and Masters by Research candidates are enrolled through UNSW Sydney and conduct their research at the Institute under the supervision of a panel approved by both UNSW and Garvan.[10]

The Institute hosts a series of free public seminars and tours every year to share its research findings and behind the scenes access to the Institute with the public.[11]

Directors

[edit | edit source]
Order Incumbent Start date End date Time in office Notes
1 John Hickie, Gerry Milton, Leslie Lazarus 1966 1969 2–3 years
2 Leslie Lazarus 1969 1990 20–21 years
3 John Shine 1990 2012 21–22 years
4 John Mattick 2012 31 May 2018 (2018-05-31) 5–6 years
5 Chris Goodnow 1 June 2018 (2018-06-01) 22 July 2022 (2022-07-22) 7 years, 359 days
6 Benjamin Kile 27 April 2023 (2023-04-27) incumbent 3 years, 29 days

Other notable staff

[edit | edit source]

See also

[edit | edit source]

Lua error in mw.title.lua at line 392: bad argument #2 to 'title.new' (unrecognized namespace name 'Portal').

References

[edit | edit source]
  1. ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
  2. ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
  3. ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
  4. ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
  5. ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
  6. ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
  7. ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
  8. ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
  9. ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
  10. ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
  11. ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
[edit | edit source]

Lua error in Module:Authority_control at line 153: attempt to index field 'wikibase' (a nil value).